152 results
Page 5 of 8
8-K
lujc3ugxcvrubcxb
25 Jul 11
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
EX-4.1
jcbgxh4
20 Apr 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-4.2
izoz elts6v5vgc0z
20 Apr 11
Unregistered Sales of Equity Securities
12:00am
8-K
fd9c0s711emvypgts9do
16 Mar 11
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
tf9j 0mpc15
1 Mar 11
Regulation FD Disclosure
12:00am
8-K
f2rwc1zmxh1jhiooz9
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
424B5
la8p2qcfrf
13 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
z7eircbm2k75bseinwv
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
EX-10.1
8njo8 l1xrag
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
424B5
l82gge
23 Dec 10
Prospectus supplement for primary offering
12:00am
8-K
EX-10.2
yl7avrfo7
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
POS AM
xsz2n
27 Jul 10
Prospectus update (post-effective amendment)
12:00am
S-3/A
jjkb2
12 Jul 10
Shelf registration (amended)
12:00am